Tailored Development Solutions for Cellular and Genetic Medicines

CRISPR is nothing short of a revolutionary advancement in science. Never before have researchers had such a precise tool with which to make controlled changes to genetic material — in plants, animals, and humans. This discovery has fueled the imaginations of researchers and innovators around the globe, and it has significantly expanded the potential for highly targeted advanced therapy medicinal products (ATMPs) in multiple therapeutic areas.

Global Cell & Gene Therapy Hub

Cell and gene therapy (CGT) trials require careful orchestration between manufacturing and patient delivery. Our experts at Worldwide have built their careers in developing complex CGT programs across North America and Europe, and their experience spans all phases, various rare and non-rare indications, and all major treatment modalities.

Optimizing Delivery with Clinical Logistics Orchestration & Management

CGT trials have unique challenges that require specialized personnel to optimize logistics, anticipate challenges, and ensure full regulatory compliance across multiple agencies. We deliver this while ensuring smooth and efficient handling of time-sensitive and temperature-sensitive critical materials.

Global Regulatory Expertise

At Worldwide, we understand the life-changing impact of novel CGT treatments requires nuanced regulatory knowledge and use our substantial expertise to optimize complex development programs with customized scientific, regulatory, medical, and operational strategies.

Meaningful Patient Community Partnerships

We partner with global patient communities to create achievable, sustainable trials that meet everyone’s needs, working tirelessly to improve the standard of care for patients with rare and complex diseases.

Meet Our Team